Medicare Part B, Breakthrough Drugs Get Reimbursement Boost In Senate COVID-19 Bill

Legislation allows sponsors to request HCPCS code even before US FDA approval, but would extend the sequester until 2030 to pay for the temporary increase in payments for Part B drugs.

United States Capitol Building in Washington DC USA
Bill Aims To Enhance Medicare Payments To Bolster Care, Innovation

A new Senate bill responding to the COVID-19 crisis includes a number of Medicare-related provisions, including one that would suspend federal budget sequestration in Medicare for six months, effectively restoring payments to average sales price plus 6% for prescription drugs covered under Part B during that time.

The Coronavirus Aid, Relief and Economic Security (CARES) Act would boost Medicare Part B drug reimbursement from the current ASP...

More from Medicare

More from Government Payers